- 12,086
- 14,908
Not Found
CytoDyn is a publicly traded late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on Leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 appears to play…
www.cytodyn.com
CytoDyn to offer laboratory testing for childhood inflammatory disease associated with COVID-19
CytoDyn is offering comprehensive cytokine profiling through its diagnostic partner, IncellDx, to help physicians understand the pathogenesis of Childhood Inflammatory Disease Related to COVID-19.
These laboratory tests are exploratory in nature and not intended for clinical decision making.
Recent reports in parts of the U.S. and Europe suggest a rare and potentially fatal inflammatory disease linked to the novel coronavirus is afflicting a small number of children.
The condition resembles a rare childhood illness called Kawasaki disease, which has similar signs and symptoms and can lead to enlargement of blood vessels that in severe forms may cause heart damage.